Unwarranted variation in care creates costs that are easy to miss: longer hospital stays, duplicated tests, inconsistent treatment patterns, and outcomes that are difficult to predict. Although EHRs capture individual clinical events, they rarely show the complete patient pathway or make it easy to compare real-world care with an evidence-based protocol.

Reducing this variation requires more than another retrospective report. Health systems need a way to reconstruct the routes patients actually take, compare those routes with expected care pathways, identify deviations associated with poorer outcomes, and continuously measure whether standardization improves results.

Kodjin Analytics by Edenlab supports this approach by bringing clinical and claims data into a shared FHIR®-based model and applying pathway, temporal, and conversational analytics. This makes variation analysis more accessible to clinical and quality leaders and helps move the process from an occasional analytics project toward a continuous improvement cycle.

Why Unwarranted Variation in Care Matters

Two patients can arrive with the same diagnosis and similar risk profiles yet experience very different journeys. One may be discharged after three days without complications, while another stays twice as long, undergoes additional imaging, and returns within 30 days. When those differences cannot be explained by patient-specific clinical needs, they represent unwarranted variation.

The financial impact is distributed across the organization rather than appearing as a single line item. It can emerge as avoidable bed-days, repeated laboratory tests, unnecessary procedures, preventable readmissions, and inconsistent resource utilization.

Research has repeatedly linked healthcare waste with low-value care and unwarranted clinical variation. For provider organizations, the issue also intersects with quality-linked reimbursement. Programs and measures such as HEDIS, CMS Star Ratings, and MIPS increasingly connect consistent, evidence-aligned care with financial performance.

Why Traditional Approaches to Care Standardization Fall Short

Most clinical and quality leaders already know that variation exists. The harder problem is seeing it with enough detail, context, and speed to change practice.

An EHR is effective at recording individual events: a laboratory order, medication administration, consultation, procedure, or discharge. But a list of events does not automatically reveal the patient journey across hundreds or thousands of comparable cases. Without interoperable and normalized data, leaders cannot easily see which treatment sequences recur, where care diverges from protocol, or whether a specific deviation is associated with a better or worse outcome.

Traditional variation analysis often compounds the problem. A central analytics team may spend weeks or months extracting, cleaning, defining, and reconciling data before presenting a retrospective report. By then, staffing, protocols, medications, or operational conditions may already have changed. The analysis can be accurate while still arriving too late to support timely improvement.

Turning Variation Analysis into a Continuous Practice

Reducing variability requires a shorter feedback loop between identifying a pattern, understanding its impact, changing practice, and measuring the result. Kodjin Analytics supports that loop through three connected capabilities.

1. A Shared Data Language for Clinical and Analytics Teams

Variation analysis often begins with disagreements over definitions: which patients belong to a cohort, which encounters constitute an episode, or what qualifies as a readmission. When clinical and technical teams use different definitions, significant time is spent reconciling them before analysis can begin.

By normalizing clinical and claims data into FHIR resources, the Kodjin data layer provides a reusable common model. Cohorts, events, and clinical concepts can be defined consistently and reused across analyses, reducing repeated data preparation and helping clinicians and analysts work from the same foundation.

2. Pathway and Temporal Analytics to Reconstruct Real Patient Journeys

Once the data is standardized, pathway and temporal analytics can reconstruct how patients move through care over time. Observed journeys can then be compared with expected protocols to identify where actual practice diverges.

The objective is not to eliminate every difference. Warranted variation reflects legitimate differences in patient needs and should remain. The analytical value comes from identifying recurring deviations that cannot be explained clinically and examining whether they correlate with outcomes such as mortality, length of stay, readmission, complications, or cost.

For example, standardized sepsis pathways have been associated with meaningful improvements in mortality and length of stay. Pathway analytics helps organizations examine similar questions in their own populations and determine where standardization may have the greatest impact.

3. Conversational Analytics for Clinical Leaders

A major barrier to continuous improvement is the reporting queue. If every follow-up question requires a new BI request, clinical investigation becomes slow and fragmented.

Kodjin Analytics adds a conversational interface that allows authorized users to ask questions in natural language, such as: “Which treatment sequences are most common for hip replacement patients?” or “Which sepsis pathways are associated with better outcomes?” Follow-up questions can build on the same analysis rather than becoming a separate reporting project.

This changes who can participate in variation analysis. Clinical leaders can explore patterns directly, identify promising practices, standardize where appropriate, and then use current data to assess whether the change improved outcomes.

From Retrospective Reporting to Continuous Variation Analytics

What the Data Foundation Must Support

Variation analytics is only as reliable as the data underneath it. Clinical and claims data must be standardized enough to reconstruct pathways consistently across systems, departments, and sites. Reliable patient identifiers and timestamps are also essential because temporal analysis depends on understanding exactly when events occurred and in what sequence.

Governance is equally important. Sensitive health data should remain within controlled infrastructure with appropriate access controls, auditability, and privacy safeguards. A governed, normalized data layer allows organizations to expand analytics without repeatedly exporting information into disconnected spreadsheets or one-off datasets.

For organizations operating across multiple EHRs or care settings, interoperability becomes especially important. A FHIR-based foundation can provide a consistent structure for analyzing pathways even when source systems differ.

How Payers Can Use Variation Analytics

Providers are the most direct users of care variation analytics, but payers also have a strong interest in the same patterns. Value-based care programs depend on understanding how clinical decisions, utilization, and outcomes vary across populations and provider networks.

When payer and provider teams can work from standardized, governed pathway data, discussions about quality and reimbursement can be grounded in a shared view of what happened across the patient journey. The same analytical foundation can also support broader population health and outcomes analysis.

Closing the Gap Between Evidence and Everyday Care

Reducing variation in care is not primarily a matter of creating more guidelines. The larger challenge is measuring how closely real patient journeys follow evidence-based practice, identifying where deviations matter, and shortening the time between insight and action.

With standardized FHIR data, pathway and temporal analytics, and conversational access to governed clinical information, Kodjin Analytics helps healthcare organizations make variation visible and measurable. Instead of treating clinical variation analysis as a quarterly project, teams can use it as an ongoing process for improving care quality, operational performance, and outcomes.

Frequently Asked Questions

What does it mean to reduce variation in care?

Reducing variation in care means decreasing unwarranted differences in how comparable patients are treated across clinicians, departments, or sites. The aim is to align practice with evidence-based protocols while preserving warranted variation that reflects genuine differences in patient needs.

Why is unwarranted variation expensive?

It can contribute to avoidable bed-days, repeated tests, unnecessary procedures, preventable readmissions, and inconsistent resource use. Because these costs appear across multiple operational and clinical areas, organizations may not see their combined impact without pathway-level analysis.

How can healthcare analytics software help reduce variation?

Healthcare analytics software can standardize data, reconstruct patient pathways, compare observed care with protocols, identify recurring deviations, and measure how those deviations relate to outcomes. Self-service analytics can also shorten the time between a clinical question and an actionable answer.

What data is needed for variation in care analytics?

Organizations typically need current clinical and claims data, consistent patient identifiers, reliable timestamps, and a standardized data model. FHIR can provide a common structure for combining information from multiple healthcare systems and supporting reusable pathway analysis.

Is variation analytics relevant only to providers?

No. Providers can use it to improve quality and operational performance, while payers can use similar insights in value-based care, network performance, and population health programs. Both benefit from standardized, governed data that supports a consistent view of patient pathways.

As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.  

Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.